Medicare Enrolled
Dr. Danny Chachere, M.D.
Neurology · Bellaire, TX
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chachere from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chachere?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chachere
Dr. Danny Chachere is a neurology specialist in Bellaire, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Chachere performed 3,065 Medicare services across 1,083 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chachere received a total of $17,922 from 69 pharmaceutical and/or device companies across 994 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chachere is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 16% volume in TX
$17,922 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,065
Medicare services
Top 16% in TX for neurology
1,083
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~219 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
2,022 | $26 | $64 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
200 | $36 | $90 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $56 | $182 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $87 | $256 |
| EEG monitoring for coma or sleep This procedure measures brain wave activity to monitor patients who are in a coma or asleep. |
87 | $46 | $112 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
87 | $95 | $235 |
| Limited needle electromyography A test that measures the electrical activity in muscles of the arm, leg, trunk, or head using a needle electrode. This limited study evaluates muscle function and nerve health. |
81 | $16 | $38 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
74 | $65 | $160 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
49 | $76 | $194 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
49 | $17 | $110 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $121 | $336 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $138 | $360 |
| New patient office visit, complex (60-74 min) | 23 | $178 | $442 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
22 | $132 | $349 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
20 | $53 | $210 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $82 | $226 |
| Intraoperative EEG monitoring Recording brain wave activity during surgery to monitor neurological function. |
15 | $43 | $104 |
| Needle EMG of muscles on both sides of body A test that measures the electrical activity in muscles using a needle electrode. The procedure is performed on muscles located on both sides of the body. |
12 | $50 | $122 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
3.7% medium
94.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,922
Total received (2018-2024)
Avg $2,560/year across 7 years
Top 18% in TX for neurology
69
Companies
994
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,710 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$213 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,087
2023
$1,984
2022
$2,450
2021
$2,868
2020
$2,116
2019
$3,398
2018
$3,019
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$1,876
Biogen, Inc.
$1,592
Alexion Pharmaceuticals, Inc.
$1,068
SK Life Science, Inc.
$969
GENZYME CORPORATION
$768
Neurocrine Biosciences, Inc.
$732
UCB, Inc.
$671
Lilly USA, LLC
$594
EMD Serono, Inc.
$582
CSL Behring
$540
Grifols USA, LLC
$518
Abbott Laboratories
$479
Sunovion Pharmaceuticals Inc.
$422
Supernus Pharmaceuticals, Inc.
$415
ACADIA Pharmaceuticals Inc
$409
Bausch Health US, LLC
$341
Amgen Inc.
$317
AbbVie Inc.
$307
Amneal Pharmaceuticals LLC
$306
PFIZER INC.
$300
Novartis Pharmaceuticals Corporation
$293
ABBVIE INC.
$281
ARBOR PHARMACEUTICALS, INC.
$265
Biohaven Pharmaceuticals, Inc.
$253
GRT US Holding, Inc.
$228
Acorda Therapeutics, Inc
$213
Avanir Pharmaceuticals, Inc.
$206
Averitas Pharma Inc.
$188
Almatica Pharma LLC
$168
Genentech USA, Inc.
$162
Allergan Inc.
$139
Allergan, Inc.
$138
Boston Scientific Corporation
$136
Greenwich Biosciences, Inc.
$136
Akcea Therapeutics, Inc.
$123
Otsuka America Pharmaceutical, Inc.
$119
Promius Pharma LLC
$113
Takeda Pharmaceuticals U.S.A., Inc.
$107
ARGENX US, INC.
$107
Assertio Therapeutics, Inc.
$106
Lundbeck LLC
$98
Biohaven Pharmaceutical Holding Company Ltd.
$85
Merz North America, Inc.
$80
ASSERTIO THERAPEUTICS, Inc.
$80
Corium, LLC
$74
Kedrion Biopharma Inc.
$65
CATALYST PHARMACEUTICALS, INC.
$58
SCILEX PHARMACEUTICALS INC.
$55
Merz Pharmaceuticals, LLC
$52
Medtronic, Inc.
$52
Adamas Pharmaceuticals, Inc.
$49
AbbVie, Inc.
$46
Impax Laboratories, Inc.
$41
Kyowa Kirin, Inc.
$39
Upsher-Smith Laboratories LLC
$39
Arbor Pharmaceuticals, Inc.
$38
Horizon Therapeutics plc
$32
Harmony Biosciences LLC
$25
SpringWorks Therapeutics, Inc.
$24
Sumitomo Pharma America, Inc.
$23
AQUESTIVE THERAPEUTICS, INC.
$22
Jazz Pharmaceuticals Inc.
$21
Mitsubishi Tanabe Pharma America, Inc.
$20
EISAI INC.
$20
GE HEALTHCARE
$20
Azurity Pharmaceuticals, Inc.
$19
LivaNova USA, Inc.
$19
Currax Pharmaceuticals LLC
$19
Kedrion Biopharma, Inc.
$17
Top 3 companies account for 25.3% of total payments
Associated products mentioned in payments ›
ACTIVA PC · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Albuked · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Briviact · CAMBIA · COPAXONE · CREXONT · Cambia · DUOPA · Duopa · EMGALITY · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gammaked · Gamunex-C · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · LEMTRADA · LYRICA · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · Mavenclad · NAMZARIC · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ongentys · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SYMPAZAN · Soliris · SpaceOAR VUE System - 10mL · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · Vimpat · Wakix · XCOPRI · XEOMIN · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZOMIG · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $585 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
387
Per 100K population
8.1
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chachere is a remote monitoring specialist, with above-average Medicare volume (top 16% in TX), with low-engagement industry engagement in the top 18% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chachere experienced with continuous intraoperative neurophysiology monitoring, remote?
Based on Medicare claims data, Dr. Chachere performed 2,022 continuous intraoperative neurophysiology monitoring, remote services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chachere receive payments from pharmaceutical companies?
Yes. Dr. Chachere received a total of $17,922 from 69 companies across 994 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chachere's costs compare to other neurologists in Bellaire?
Dr. Chachere's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chachere) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bellaire
Browse neurologists in Bellaire ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology